Huber et al., analysing the TME of melanoma, found an increased level of High-Mobility Group Box 1 protein (HMGB1) levels in patients’ serum, compared to the healthy patients, secreted by the melanoma tumour. This evidence concerns the gene HMGB1 and melanoma.